Bayer, DE000BAY0017

Bayer stock heads into the open after a 1.09 percent Xetra loss

Published on 09/14/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, Bayer stock finished at 48.17 euros on Xetra, down 1.09 percent on the day. The shares sat about 11 percent below their 52-week high, while the DAX home index also advanced modestly in the same session.

Forscherin im weißen Kittel pipettiert an einem beleuchteten Laborarbeitsplatz vor einem Bildschirm mit 3D-Molekülstruktur
Pharmazeutisches Forschungslabor – Wissenschaftlerin mit Pipette, Molekülstruktur-Monitor, blaue LED-Beleuchtung, Illustration mit AI erstellt.

Bayer stock closed at 48.17 euros on Xetra on September 11, 2026, losing 1.09 percent versus the previous session.

Zonebourse data cited in a recent overview show that this close left the shares roughly 11 percent below their 52-week high of 53.86 euros and about 1.39 percent under their level at the start of 2026, with a one year performance of around plus 30.15 percent, illustrating a strong recovery over twelve months despite a consolidation this year.Ad-hoc-news

September 11, 2026 Xetra close in focus

Bayer AG (ISIN DE000BAY0017) ended the September 11, 2026 Xetra session at 48.17 euros, matching quote overviews that list a day range between about 49.10 and 47.74 euros and a one day move of minus 1.09 percent, based on a trading volume of roughly 2.44 million shares on the venue per Investing.com data.

According to a recent market wrap, the Xetra close left Bayer stock around 11 percent below its 52-week high of 53.86 euros, while the one year performance stood near plus 30.15 percent and the year to date change around minus 1.39 percent, underscoring how the shares have rebounded over the past year even as 2026 has been more muted.Ad-hoc-news

Today’s backdrop for Bayer stock

In the same September 11, 2026 session, the DAX home index closed higher, with a gain of about 207 points to 25,568.56, providing a constructive backdrop for large German names even as Bayer lagged that broader move.Minkabu Company and sector news around legal and strategic topics, including ongoing Roundup-related proceedings and discussions about a potential collaboration with partners in Abu Dhabi, remain part of the wider narrative that investors monitor into today’s session.Ad-hoc-news

Disclaimer...

en | DE000BAY0017 | BAYER | boerse | 70097615 | bgmi